Assessment of the Relationship between Body Mass Index and Incidence of Venous Thromboembolism in Hospitalized Overweight and Obese Patients
Authors:
- 21 June 2017
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 37 (8) , 893-899
Abstract
Study Objective: To assess whether a positive linear association exists between body mass index (BMI) and incidence of venous thromboembolism (VTE) in overweight and obese hospitalized patients.Design: Single‐center retrospective observational cohort study.Setting: Large academic tertiary care medical center.Patients: A total of 1452 adults hospitalized between January 1, 2013, and December 31, 2014, who weighed more than 100 kg and had a BMI of 25 kg/m2 or greater on admission, and received heparin subcutaneously for VTE prophylaxis. Patients were categorized into four subgroups based on World Health Organization BMI classification: overweight (141 patients), obese class I (305 patients), obese class II (324 patients), and obese class III (682 patients).Measurements and Main Results: The primary outcome was occurrence of VTE in each subgroup; all‐cause mortality and length of hospital stay were secondary outcomes. A linear trend test did not show an association between occurrence of VTE and BMI of 25 kg/m2 or greater. VTE occurred in 7 (5%) of 141 patients in the overweight group, 5 (2%) of 305 in the obese class I group, 8 (3%) of 324 in the class II group, and 18 (3%) of 682 in the class III group (p=0.573). In addition, no linear association was noted between all‐cause mortality or length of hospital stay and BMI of 25 kg/m2 or greater. Overall mortality was 10% (146/1452 patients). Ten deaths (7%) occurred in the overweight group, 45 (15%) in the obese class I group, 38 (12%) in the obese class II group, and 53 (8%) in the obese class III group (p=0.067). The median length of hospital stay was 5 days (interquartile range 3–9, p=0.122) for all patients.Conclusion: In overweight and obese hospitalized patients who weighed more than 100 kg and had a BMI of 25 kg/m2 or greater, the incidence of VTE did not increase incrementally with increasing severity of obesity.Keywords
This publication has 21 references indexed in Scilit:
- Impact of practice change in reducing venous thromboembolism in neurocritical overweight patients: 2008–2014Journal of Thrombosis and Thrombolysis, 2016
- Safety and Efficacy of High‐Dose Unfractionated Heparin for Prevention of Venous Thromboembolism in Overweight and Obese PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized PatientsHospital Pharmacy, 2016
- High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patientsJournal of Thrombosis and Thrombolysis, 2015
- Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatientsThrombosis and Haemostasis, 2014
- Body Mass Index, Surgery, and Risk of Venous Thromboembolism in Middle-Aged WomenCirculation, 2012
- Prospective Study of BMI and the Risk of Pulmonary Embolism in WomenObesity, 2009
- Overweight, Obesity, and the Risk of Recurrent Venous ThromboembolismArchives of internal medicine (1960), 2008
- Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registryJournal of Thrombosis and Haemostasis, 2008
- Body mass index and the risk of venous thrombosis among postmenopausal womenJournal of Thrombosis and Haemostasis, 2006